CANCER: Second-line chemotherapy patients benefit from vandetanibDrop of 21% in risk of disease progression seen after 13-month followup CANCER: Pemetrexed boosts non-small cell survival ratesPatients with nonsquamous cell carcinoma live up to 5.2 months longer, research shows Income gap in Ontario cancer screening Low rate of follow-up care to abnormal Pap tests Annual screening for skin cancer: Reasons for non-compliance Breast cancer testing to restart Ovary removal linked to higher risk of lung cancer Canadian researcher says result is preliminary, but intriguing Ovarian Cancer Helping patients navigate treatment courses and manage side effects CANCER: Anal cancer gold standard remains best approach Mutant cows make anti-carcinogenic milk CANCER: New gene assay predicts colon cancer recurrence First Previous 80 81 82 83 84 Next Last
